Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Desmoplastic Small Round Cell Tumor × Irinotecan × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 62 Pancreatic Neoplasms 29 Neoplasm Metastasis 20 Neuroblastoma 16 Colonic Neoplasms 16 Neoplasms 15 Stomach Neoplasms 13 Rectal Neoplasms 9 Sarcoma, Ewing 8 Rhabdomyosarcoma 7 Esophageal Squamous Cell Carcinoma 7 Ovarian Neoplasms 6 Sarcoma 5 Adenocarcinoma Of Esophagus 5 Small Cell Lung Carcinoma 4 Medulloblastoma 4 Lung Neoplasms 4 Esophageal Neoplasms 4 Endometrial Neoplasms 4 Cholangiocarcinoma 4 Breast Neoplasms 4 Recurrence 3 Osteosarcoma 3 Glioblastoma 3 Gastrointestinal Neoplasms 3 Ependymoma 3 Carcinoma, Non-Small-Cell Lung 3 Adenocarcinoma 3 Wilms Tumor 2 Uterine Cervical Neoplasms 2

Interventions

Cyclophosphamide 3 fludarabine phosphate 2 Vincristine 2 Temozolomide 2 PM 01183 2 Etoposide 2 thymoglobulin 1 temsirolimus 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 fludarabine 1 Zoledronic Acid 1 Vinorelbine 1 Thiotepa 1 Tacrolimus 1 Surgical Procedures, Operative 1 Stem Cell Transplantation 1 Sorafenib 1 Ramucirumab 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Proton Therapy 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Irinotecan 1 Injections 1 Ifosfamide 1 Granulocyte Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07328425 2026-01-12

ISG-TULIPS

Italian Sarcoma Group

Phase 2 Recruiting

Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡